A historic alliance of top cannabidiol (CBD) companies advocating for legislation and FDA regulation of hemp-derived CBD products as dietary supplements launched Tuesday.
U.S. stocks traded lower midway through trading, with the Dow Jones falling more than 200 points on Tuesday.
The Dow traded down 0.69% to 34,384.29 while the NASDAQ fell 0.82% to 13,597.78. The S&P 500 also fell, dropping, 0.63% to 4,425.66.
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) announced that the INTEGUMENT-PED Phase 3 trial of roflumilast cream 0.05%, in children ages 2 to 5 years with mild to moderate atopic dermatitis met its primary endpoint